Award recordCONTRACT

INTERCEPT PHARMACEUTICALS INC

PIID VA26117F2290· VHA· 261-NETWORK CONTRACT OFFICE 21 (36C261)· 6505 · DRUGS AND BIOLOGICALS· FY2017· $0 net obligations· UEI GHNKCLBJRMK7· NY

Description

OBETICHOLIC ACID 5MG

First action · last action
2017-07-19 · 2019-04-04
Transactions
2
First transaction's obligation
$17,064
Base + all options value (sum of deltas)
$0
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
V797D70027
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 2 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$17,064$0Base award · 2017-07-19 · this action $17,064 · running total $17,064Modification P00001 · 2019-04-04 · this action -$17,064 · running total $0
  • Base2017-07-19+$17,064= $17,064
  • Mod P000012019-04-04-$17,064= $0
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2017-07-19+$17,064$17,064OBETICHOLIC ACID 5MG
Mod P00001· OTHER ADMINISTRATIVE ACTION2019-04-04−$17,064$0OBETICHOLIC ACID 5MG

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI GHNKCLBJRMK7)

AwardOffice · PSC / listingNet obligationsFY
36E79725A0001NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2025
36F79724D0180NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS$0FY2024
36E79722A0011NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2022
36C24920F0531249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS$49,147FY2020
36C24719K0039247-NETWORK CONTRACT OFFICE 7 (36C247) · 6505 · DRUGS AND BIOLOGICALS$4,363FY2019
36C26119F0005261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS$26,401FY2019

Other recipients under 6505 from 261-NETWORK CONTRACT OFFICE 21 (36C261) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26126P1178OPTUM FRONTIER THERAPIES II, LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$58,374FY2026
36C26126P1102ENVIGO RMS LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$74,586FY2026
36C26126P096110X GENOMICS, INC.261-NETWORK CONTRACT OFFICE 21 (36C261)$34,600FY2026
36C26126P0997SIERRA RADIOPHARMACY LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$247,204FY2026
36C26126P1008OPTUM FRONTIER THERAPIES II, LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$58,374FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26117F2290_3600_V797D70027_3600 · retrieved 2026-09-26.